Table 5.
Serum FST levels in patients with LADC according to TNM staging
| n | Mean ± SD, pg/mL | Minimum–maximum, pg/mL | |
|---|---|---|---|
| Healthy subjects | 37 | 760.09 ± 115.65 | 570.88–1170.24 |
| Benign diseases | 22 | 1225.60 ± 323.40# | 608.36–1763.76 |
| LADC | 33 | ||
| I | 14 | 1404.69 ± 245.02# | 877.29–1900.14 |
| II | 5 | 1409.18 ± 199.51# | 1150.05–1763.76 |
| III | 7 | 1578.68 ± 276.90#* | 1150.05–2104.71 |
| IV | 7 | 1802.73 ± 311.12#**S | 1150.05–2241.09 |
#P < 0.01 compared with the healthy group; * P < 0.05, ** P < 0.01, compared with benign disease group; SP < 0.05, compared with I and II stage group